Posted by Michael Wonder on 28 Sep 2023
Merck, AstraZeneca, Bristol Myers Squibb to participate in Medicare drug price negotiations
27 September 2023 - All four pharmaceutical companies have sued to halt the process.
Merck, AstraZeneca, Bristol Myers Squibb and Boehringer Ingelheim on Wednesday told CNBC they will agree to participate in the first round of Medicare drug price negotiations, even after all four drugmakers sued to halt the process last month.
